C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese

Código QR

C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese

Angelo C Dongway,1 Areeg S Faggad,2,3 Hani Y Zaki,2 Badreldin E Abdalla,2,41Department of Biochemistry, Faculty of Medicine, Upper Nile University, Malakal, South Sudan; 2Department of Biochemistry and Nutrition, Faculty of Medicine, University of Gezira, 3Department of Molecular Biology, National C...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dongway AC, Faggad AS, Zaki HY, Abdalla BE
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/94f201873acc4c70b61cb24b7240fde6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
por: Babakr AT, et al.
Publicado: (2014)

Polymorphism Of The APM1 Gene In Subjects With Central Obesity Related To Lower High-Density Lipoprotein Cholesterol
por: Barliana MI, et al.
Publicado: (2019)

Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
por: Cuevas-Ramos D, et al.
Publicado: (2013)

The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu W, et al.
Publicado: (2020)

Comparison of the Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Lymphocyte to High-Density Lipoprotein Cholesterol Ratio for Predicting Metabolic Syndrome Among a Population in the Southern Coast of China
por: Chen T, et al.
Publicado: (2020)

Threshold Effects in the Relationship Between Serum Non-High-Density Lipoprotein Cholesterol and Metabolic Syndrome
por: Wang S, et al.
Publicado: (2019)

A Non-Linear Association of High-Density Lipoprotein Cholesterol with All-Cause and Cause-Specific Mortality in Diabetic Patients
por: Yan Y, et al.
Publicado: (2021)

Obstructive sleep apnea and bone mineral density in obese patients
por: Mariani S, et al.
Publicado: (2012)

Association of salivary C-reactive protein with the obesity measures and markers in children
por: Selvaraju V, et al.
Publicado: (2019)

Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity
por: Rolf P Kreutz, et al.
Publicado: (2011)

Detrimental Effect of C-Reactive Protein on the Cardiometabolic Cells and Its Rectifying by Metabolic Surgery in Obese Diabetic Patients
por: Sun F, et al.
Publicado: (2020)

Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants
por: Marion L Vetter, et al.
Publicado: (2010)

Triglyceride to High-Density Lipoprotein Cholesterol Ratio is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study
por: Zhang B, et al.
Publicado: (2020)

High-sensitivity C-reactive protein concentrations among patients with and without diabetes in a multiethnic population of Singapore: CREDENCE Study
por: Rinkoo Dalan, et al.
Publicado: (2010)

Mechanism linking diabetes mellitus and obesity
por: Al-Goblan AS, et al.
Publicado: (2014)

Associations of Metabolic/Obesity Phenotypes with Insulin Resistance and C-Reactive Protein: Results from the CNTR Study
por: Liao C, et al.
Publicado: (2021)

Morning cortisol is lower in obese individuals with normal glucose tolerance
por: Praveen EP, et al.
Publicado: (2011)

Linking obesity with type 2 diabetes: the role of T-bet
por: Wali JA, et al.
Publicado: (2014)

Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants
por: Vetter M, et al.
Publicado: (2010)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander PA
Publicado: (2012)

Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome
por: Smith CJ, et al.
Publicado: (2015)

Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
por: Chen H, et al.
Publicado: (2019)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
por: Shitalkumar P Zambad, et al.
Publicado: (2011)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
por: Dara P Schuster
Publicado: (2010)

Management of diabetes across the course of disease: minimizing obesity-associated complications
por: Apovian CM
Publicado: (2011)

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
por: Leng W, et al.
Publicado: (2021)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
por: Angel Rodr&iacute;guez, et al.
Publicado: (2010)

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
por: Amy Fleischman, et al.
Publicado: (2009)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
por: Bradley Curtis, et al.
Publicado: (2008)

Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
por: Gruzdeva O, et al.
Publicado: (2013)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam &ndash; a clinical perspective
por: Ronald B Goldberg
Publicado: (2009)

Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
por: Raffaelli M, et al.
Publicado: (2015)

Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
por: Oh S, et al.
Publicado: (2014)

Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
por: Stephen CL Gough, et al.
Publicado: (2009)

Is obesity in women protective against osteoporosis?
por: Migliaccio S, et al.
Publicado: (2011)

Causes and consequences of obesity: epigenetics or hypokinesis?
por: Graham MR, et al.
Publicado: (2015)

The economic impact of obesity in the United States
por: Ross A Hammond, et al.
Publicado: (2010)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Chandni Bardolia, et al.
Publicado: (2021)

A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype
por: Dalleck LC, et al.
Publicado: (2014)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
por: Colosia AD, et al.
Publicado: (2013)